eMed focuses on employer-sponsored preemptive health management, providing personalized solutions for workforce health.
eMed has raised $200.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.
eMed's investors include R.J. Melman, Ara Cohen, Aon, Joe Lonsdale, Antonio Gracias.
eMed is headquartered in Miami, United States.
eMed focuses on employer-sponsored preemptive health management, providing personalized solutions for workforce health.
eMed is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"eMed — Funding & Investors." VCBacked, March 26, 2026, https://www.vcbacked.co/company/emed. Accessed October 9, 2026.
VCBacked. (2026). eMed — Funding & Investors. Retrieved October 9, 2026, from https://www.vcbacked.co/company/emed
{{cite web |title=eMed — Funding & Investors |url=https://www.vcbacked.co/company/emed |website=VCBacked |access-date=October 9, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated